Tau Kinetics in Neurons and the Human Central Nervous System

Sato, Chihiro, Barthélemy, Nicolas R., Mawuenyega, Kwasi G., Patterson, Bruce W., Gordon, Brian A., Jockel-Balsarotti, Jennifer, Sullivan, Melissa, Crisp, Matthew J. +9 more·2018·Neuron

DOI 10.1016/j.neuron.2018.02.015

Cited by (584)

Items 301–400 of 584

Molecular abnormalities in autopsied brain tissue from the inferior horn of the lateral ventricles of nonagenarians and Alzheimer disease patients
Andrew Pearson, Rosa Ajoy, Gogce C. Crynen, Jon M. Reed, Moustafa Algamal, MICHAEL J. MULLAN, Dushyant P. Purohit, Fiona Crawford, Joseph O. Ojo · 2020 · BMC Neurology
Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood
Jianman Wang, Xing Lu, Yao He · 2025 · Biosensors
Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models
Zhihui Jin, Yan Lu, Huifang Tang, Huashun Cui · 2025 · Alzheimer s & Dementia
Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer’s Disease Pathology
Takeshi Kawarabayashi, Takumi Nakamura, Kaoru Sato, Yusuke Seino, Sadanobu Ichii, Naoko Nakahata, Masamitsu Takatama, David A. Westaway, Peter St George‐Hyslop, Mikio Shoji · 2022 · Journal of Alzheimer s Disease
Caspase‐6‐cleaved tau is relevant in Alzheimer's disease and marginal in four‐repeat tauopathies: Diagnostic and therapeutic implications
Panos Theofilas, Antonia M. H. Piergies, Ian Michael Oh, Yoo Bin Lee, Song Hua Li, Felipe Luiz Pereira, Cathrine Petersen, Alexander J. Ehrenberg, Rana April Eser, Andrew J. Ambrose et al. · 2022 · Neuropathology and Applied Neurobiology
CSF biomarkers in patients with epilepsy in Alzheimer’s disease: a nation-wide study
Rakesh Kumar Banote, Samuel Håkansson, Henrik Zetterberg, Johan Zelano · 2022 · Brain Communications
The 2024 NIA-AA biological definition of Alzheimer’s disease: linking biomarkers to clinical practice
Goh Kobayashi, Kosei Hirata, Maiko Ono, Kensaku Kasuga, Yuhei Takado · 2026 · Frontiers in Dementia
MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
Chihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, Brenton A. Wright, Gregory Scott Day, Albert A. Davis, Albert H. Kim, Gregory Joseph Zipfel, Randall John Bateman, Audrey Gabelle et al. · 2021 · Annals of Clinical and Translational Neurology
Tau kinetics in Alzheimer's disease
Daniel B. Hier, Sima Azizi, Matthew S. Thimgan, Donald C. Wunsch · 2022 · Frontiers in Aging Neuroscience
Unraveling the Potential of EphA4: A Breakthrough Target and Beacon of Hope for Neurological Diseases
Meenal Verma, Manjeet Chopra, Hemant Kumar · 2023 · Cellular and Molecular Neurobiology
Long non-coding RNA SNHG8 drives stress granule formation in tauopathies
Reshma Bhagat, Miguel Minaya, Arun Renganathan, Muneshwar Mehra, Jacob A. Marsh, Rita J. Martinez, Abdallah M. Eteleeb, Alissa L. Nana, Salvatore Spina, William W. Seeley et al. · 2023 · Molecular Psychiatry
Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer’s disease
Yan Lian, Yujuan Jia, Joelyn Wong, Xin‐Fu Zhou, Weihong Song, Junhong Guo, Colin Louis Masters, Yan‐Jiang Wang · 2023 · Molecular Psychiatry
Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases
Ann Brinkmalm, Erik Portelius, Gunnar Brinkmalm, Josef Pannee, Rahil Dahlén, Johan Gobom, Kaj Blennow, Henrik Zetterberg · 2018 · Journal of Neurochemistry
Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid
Gallen Triana‐Baltzer, Kristof Van Kolen, Clara Theunis, Setareh Moughadam, Randy Slemmon, Marc H. Mercken, Wendy R. Galpern, Hong Fan Sun, Hartmuth Christian Kolb · 2020 · Journal of Alzheimer s Disease
Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer’s Disease
Mohammad Arastoo, Richard A. Lofthouse, Lewis K. Penny, Charles R. Harrington, Andy Porter, Claude M. Wischik, Soumya Palliyil · 2020 · International Journal of Molecular Sciences
Tau Is Truncated in Five Regions of the Normal Adult Human Brain
Michael G. Friedrich, Amanda S. Skora, Sarah E. Hancock, Todd W. Mitchell, Paul Lewis Else, Roger J.W. Truscott · 2021 · International Journal of Molecular Sciences
Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains
Soumya Mukherjee, Céline Dubois, Keyla A. Perez, Shiji Varghese, Ian E. Birchall, Miranda Leckey, Natalia Davydova, Catriona McLean, Rebecca M. Nisbet, Blaine Russell Roberts et al. · 2022 · Journal of Neurochemistry
Development of MAPT S305 mutation human iPSC lines exhibiting elevated 4R tau expression and functional alterations in neurons and astrocytes
Kathryn R. Bowles, Chiara Pedicone, Derian A. Pugh, Laura‐Maria Oja, Filipa H. Sousa, Lois Keavey, Brian Fulton‐Howard, Sarah A. Weitzman, Yiyuan Liu, Jonathan L. Chen et al. · 2024 · Cell Reports
Glymphatic function associates with Alzheimer’s disease—signature region volumes, plasma biomarkers and white matter hyperintensity progression in cognitively unimpaired older adults
Qian Chen, Danni Ge, Xinru Xu, Futao Chen, Shunshun Du, Yijun Bai, Dongming Liu, Yan Lei, Yajing Zhu, Cong Long et al. · 2025 · Age and Ageing
Cerebrospinal Fluid and Plasma Tau as a Biomarker for Brain Tauopathy
Mikio Shoji · 2019 · Advances in experimental medicine and biology
Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline
Wiesje Pelkmans, Eleonora M. Vromen, Ellen Dicks, Philip Scheltens, Charlotte Elisabeth Teunissen, Frederik Barkhof, Wiesje M. van der Flier, Betty Marije Tijms, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Brain Communications
Gut Microbiota and Immunotherapy for Alzheimer’s Disease
Chun‐Ling Dai, Fei Liu, Khalid Iqbal, Cheng‐Xin Gong · 2022 · International Journal of Molecular Sciences
Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody
Kristof Van Kolen, T. Malia, Clara Theunis, Rupesh K. Nanjunda, A. Teplyakov, Robin Ernst, Sheng‐Jiun Wu, Jinquan Luo, Marianne Borgers, Marc Vandermeeren et al. · 2020 · Journal of Alzheimer s Disease
Association between gray matter atrophy, cerebral hypoperfusion, and cognitive impairment in Alzheimer’s disease
Haoyang Dong, Lining Guo, Hailei Yang, Wenshuang Zhu, Fang Liu, Yingying Xie, Yu Zhang, Kaizhong Xue, Qiang Li, Meng Liang et al. · 2023 · Frontiers in Aging Neuroscience
Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers
Val J. Lowe, Carly T. Mester, Emily S. Lundt, Jeyeon Lee, Sujala Ghatamaneni, Alicia Algeciras‐Schimnich, Michelle Renee Campbell, Jonathan Graff‐Radford, Aivi T. Nguyen, Hoon-Ki Paul Min et al. · 2024 · Alzheimer s & Dementia
Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia
Liu, Andy J., Staffaroni, Adam M., Rojas-Martinez, Julio C., Olney, Nicholas T., Alquezar-Burillo, Carolina, Ljubenkov, Peter A., La Joie, Renaud, Fong, Jamie C., Taylor, Joanne, Karydas, Anna et al. · 2020 · JAMA Neurology
Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer’s Disease: A Review and Meta-Analysis
Gemma Lombardi, Silvia Pancani, Riccardo Manca, Micaela Mitolo, Simone Baiardi, Federico Massa, Luigi Coppola, Monica Franzese, Emanuele Nicolai, Franca Rosa Guerini et al. · 2024 · International Journal of Molecular Sciences
Exercise training exerts beneficial effects on Alzheimer’s disease through multiple signaling pathways
Jihe Kang, Mei Liu, Qiang Yang, Xiangji Dang, Qun Li, Ting Wang, Bin Qiu, Yibao Zhang, Xudong Guo, Xiaoling Li et al. · 2025 · Frontiers in Aging Neuroscience
PLCγ2 impacts microglia-related effectors revealing variants and pathways important in Alzheimer’s disease
Li, Ke, Ran, Beibei, Wang, Yu, Liu, Lulu, Li, Weidong · 2022 · Frontiers in Cell and Developmental Biology
Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia
Guido Maria Giuffrè, Davide Quaranta, Emanuele Maria Costantini, Salvatore Citro, Noemi Martellacci, Grazia De Ninno, Maria Gabriella Vita, Valeria Guglielmi, Paolo Maria Rossini, Paolo Calabresi et al. · 2023 · Neurobiology of Disease
Gut dysbiosis, insulin resistance and Alzheimer’s disease: review of a novel approach to neurodegeneration
Evelyn B. Lazar, Ayesha Z. Sherzai, Jennifer O. Adeghate, Dean Sherzai · 2021 · Frontiers in Bioscience-Scholar
Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker cis P-tau by a Label-Free Electrochemical Immunosensor
Ayoub Shiravandi, Farzaneh Yari, Nahid Tofigh, Mohammad Kazemi Ashtiani, Koorosh Shahpasand, Mohammad Hossein Ghanian, Faezeh Shekari, Farnoush Faridbod · 2022 · Biosensors
Human chaperones untangle fibrils of the Alzheimer protein Tau
Luca Ferrari, Willie J. C. Geerts, Marloes D. van Wezel, Renate Kos, Aikaterini Konstantoulea, Laura S. van Bezouwen, Friedrich G. Förster, Stefan Rüdiger · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
The two cut‐offs approach for plasma p‐tau217 in detecting Alzheimer's disease in subjective cognitive decline and mild cognitive impairment
Giulia Giacomucci, Chiara Crucitti, Assunta Ingannato, Valentina Moschini, Silvia Bagnoli, Federico Emanuele Pozzi, Elisa Marcantelli, Sonia Padiglioni, Carmen Morinelli, Salvatore Mazzeo et al. · 2025 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Recombinant production and purification of the human protein Tau
Luca Ferrari, Stefan Rüdiger · 2018 · Protein Engineering Design and Selection
Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiationin Vivo
Tomáš Ondrejčák, Igor V. Klyubin, Neng‐Wei Hu, Tiernan T. O’Malley, Grant T. Corbett, Róisín Winters, Michael S. Perkinton, Andy Billinton, Jack A. Prenderville, Dominic M. Walsh et al. · 2023 · Journal of Neuroscience
Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology
Stephen P. Schauer, Balázs István Tóth, Julie Lee, Lee A. Honigberg, Vidya Ramakrishnan, Jenny Z. Jiang, Gwendlyn Kollmorgen, Anna Bayfield, Norbert Wild, Jennifer Hoffman et al. · 2024 · Alzheimer s & Dementia
Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain
Atsuko Kubo, Shouyou Ueda, Ayaka Yamane, Satoko Wada‐Kakuda, Mai Narita, Makoto Matsuyama, Akane Nomori, Akihiko Takashima, Taisuke Kato, Osamu Onodera et al. · 2019 · Journal of Neuroscience
Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?
Xun Gong, Hantao Zhang, Xiaoyan Liu, Yi Liu, Junlin Liu, Funmilayo Omotoyosi Fapohunda, Peng Lü, Kun Wang, Min Tang · 2022 · Frontiers in Aging Neuroscience
Sleep and Alzheimer: The Link
Archana Gaur T, Ariyanachi Kaliappan, Yuvaraj Balan, Varatharajan Sakthivadivel, Kalpana Medala, Madhusudhan Umesh · 2022 · MAEDICA – a Journal of Clinical Medicine
Combination Therapy for the Treatment of Alzheimer’s Disease: Recent Progress and Future Prospects
Ekta Shirbhate, Vijay K. Patel, Priya Tiwari, Rakesh Kore, Ravichandran Veerasamy, Achal Mishra, Harish Rajak · 2022 · Current Topics in Medicinal Chemistry
Relationship of Apolipoprotein E with Alzheimer’s Disease and Other Neurological Disorders: An Updated Review
Tian-Wen Lou, Borui Tao, Ming Chen · 2023 · Neuroscience
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Claudia Cicognola, Oskar Hansson, Philip Scheltens, Hlin Kvartsberg, Henrik Zetterberg, Charlotte Elisabeth Teunissen, Kaj Blennow · 2021 · Alzheimer s Research & Therapy
Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
Julia Remnestål, Sofia Bergström, Jennie Olofsson, Evelina Sjöstedt, Mathias Uhlén, Kaj Blennow, Henrik Zetterberg, Anna Zettergren, Silke Kern, Ingmar Gr. Skoog et al. · 2021 · Alzheimer s Research & Therapy
Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease
Kanta Horie, Yan Li, Nicolas R. Barthélemy, Brian Andrew Gordon, Jason J. Hassenstab, Tammie L.S. Benzinger, Anne M. Fagan, John C. Morris, Celeste M M. Karch, Chengjie Xiong et al. · 2023 · Annals of Neurology
Protein kinetics of superoxide dismutase‐1 in familial and sporadic amyotrophic lateral sclerosis
Cindy V. Ly, Margaret D. Ireland, Wade K. Self, James Bollinger, Jennifer Jockel, Hillary Herzog, Peggy Allred, Leah Miller, Michael Doyle, Isabel Anez-Bruzual et al. · 2023 · Annals of Clinical and Translational Neurology
Tanycytic degeneration impairs tau clearance and contributes to Alzheimer’s disease pathology
Florent Sauvé, Ricardo Gomez-Martínez, Yvon Mbouamboua, Gaëtan Ternier, Sreekala S. Nampoothiri, Elian Dupré, Lolie Garcia, Marie Couralet, Julie Dewisme, Thibaud Lebouvier et al. · 2026 · Cell Press Blue
One decade ago, one decade ahead in progressive supranuclear palsy
María Stamelou, Nikolaos Giagkou, Günter U. Höglinger · 2019 · Movement Disorders
ELISA Evaluation of Tau Accumulation in the Brains of Patients with Alzheimer Disease
Mitsuru Shinohara, Junko Hirokawa, Akemi Shimodaira, Yoshitaka Tashiro, Kaoru Suzuki, Ghupurjan Gheni, Akio Fukumori, Tomoyasu Matsubara, Maho Morishima, Yuko Saito et al. · 2021 · Journal of Neuropathology & Experimental Neurology
Therapeutic strategies for tauopathies and drug repurposing as a potential approach
Majedul Islam, Fengyun Shen, Deepika Regmi, Deguo Du · 2022 · Biochemical Pharmacology
Protein turnover models for LC–MS data of heavy water metabolic labeling
Rovshan G. Sadygov · 2021 · Briefings in Bioinformatics
Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials
Xiaoni Zhan, Gehua Wen, Xu Wu, Jiayi Li · 2025 · Translational Neurodegeneration
Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond
Carl Alexander Sandhof, Heide F.B. Murray, M. Catarina Silva, Stephen J. Haggarty · 2024 · Neurotherapeutics
Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau
Abhirami Kannan Iyer, Lisa Vermunt, Farzaneh Sadat Mirfakhar, Miguel Minaya, Mariana Acquarone, Rama K. Koppisetti, Arun Renganathan, Shih‐Feng You, Emma Danhash, Kylie J. Schache et al. · 2025 · Molecular Psychiatry
Biomarker-related phospho-tau217 appears in synapses around Aβ plaques prior to tau tangle in cerebral cortex of preclinical Alzheimer’s disease
Yu Hirota, Yasufumi Sakakibara, Maho Morishima, Terunori Sano, Manato Hara, Akira Arakawa, Masaki Takao, Shigeo Murayama, Yuko Saito, Michiko Sekiya et al. · 2025 · Cell Reports
Tracking the potential involvement of metabolic disease in Alzheimer's disease—Biomarkers and beyond
Jose Alejandro Luchsinger, Henrik Zetterberg · 2020 · International review of neurobiology
Simple, Single-Shot Phosphoproteomic Analysis of Heat-Stable Tau Identifies Age-Related Changes in pS235- and pS396-Tau Levels in Non-human Primates
Shannon N. Leslie, Jean E. Kanyo, Dibyadeep Datta, Rashaun S. Wilson, Caroline J. Zeiss, Alvaro Duque, TuKiet T. Lam, Amy F.T. Arnsten, Angus Clark Nairn · 2021 · Frontiers in Aging Neuroscience
Targeted proteolytic products of τ and α-synuclein in neurodegeneration
Yuxing Xia, Grace M. Lloyd, Benoit I. Giasson · 2021 · Essays in Biochemistry
Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage
Claudia Cicognola, Tuğçe Munise Şatır, Gunnar Brinkmalm, Irena Matečko‐Burmann, Lotta Agholme, Petra Bergström, Bruno Becker, Henrik Zetterberg, Kaj Blennow, Kina Höglund · 2020 · Journal of Alzheimer s Disease
Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard
Maotian Zhou, Duc Minh Duong, Erik C. B. Johnson, Jingting Dai, James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2019 · Journal of Proteome Research
NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression
Mengel, David, Mok, Tze How, Nihat, Akin, Liu, Wen, Rissman, Robert A., Galasko, Douglas, Zetterberg, Henrik, Mead, Simon, Collinge, John, Walsh, Dominic M. · 2021 · Cells
Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges
Chenxi He, Jinying Gu, Danni Wang, Keran Wang, Yuxuan Wang, Qidong You, Lei Wang · 2023 · European Journal of Medicinal Chemistry
Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Victor Cuevas-Espinoza, Rodrigo A. Quintanilla · 2024 · Ageing Research Reviews
Plasma N‐terminal tau fragment is an amyloid‐dependent biomarker in Alzheimer's disease
Guoyu Lan, Laihong Zhang, Anqi Li, Wenqing Ran, Jieqin Lv, Fernando González‐Ortiz, Yue Qin Cai, Pan Sun, Lin Liu, Jie Yang et al. · 2025 · Alzheimer s & Dementia
Tau phosphorylation at Alzheimer's disease biomarker sites impairs its cleavage by lysosomal proteases
Courtney Lane‐Donovan, Andrew W. Smith, Rowan Saloner, Bruce L. Miller, Kaitlin Blackstone Casaletto, Aimee W. Kao · 2025 · Alzheimer s & Dementia
Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids
Peng-Ming Zeng, Xin-Yao Sun, Yang Li, Wen-di Wu, Jing Huang, Dong-Dong Cao, Pin-jue Qian, Xiang-Chun Ju, Zhen‐Ge Luo · 2025 · Stem Cell Reports
Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia
Charles Arber, Argyro Alatza, Claire Alexandra Leckey, Ross W. Paterson, Henrik Zetterberg, Selina Wray · 2021 · Journal of Neurochemistry
Epigenetic axis of SNHG19/miR-137/TNFAIP1 modulates amyloid beta peptide 25–35-induced SH-SY5Y cytotoxicity
Yipei Li, Li Jin, Fang Wang, Li Ren, Ruirui Pen, Guojia Bo, Li Wang · 2022 · Epigenomics
The transformative potential of plasma phosphorylated tau
Clifford R. Jack · 2020 · The Lancet Neurology
Examining Targeted Protein Degradation from Physiological and Analytical Perspectives: Enabling Translation between Cells and Subjects
Natalie A. Daurio, Haihong Zhou, Ying Chen, Payal R. Sheth, Jason E. Imbriglio, David G. McLaren, Paul Tawa, Nadia Rachdaoui, Michael J. Previs, Takhar Kasumov et al. · 2020 · ACS Chemical Biology
Structural characterization of monoclonal antibodies targeting C-terminal Ser404 region of phosphorylated tau protein
Jessica E. Chukwu, Erin E. Congdon, Einar M. Sigurdsson, Xiang‐Peng Kong · 2019 · mAbs
Cerebrospinal fluid p‐tau181, 217, and 231 in definite Creutzfeldt–Jakob disease with and without concomitant pathologies
Andreja Emeršič, Nicholas James Ashton, Agathe Vrillon, Juan Lantero‐Rodriguez, Jernej Mlakar, Milica Gregorič Kramberger, Fernando González‐Ortiz, Przemysław Radosław Kac, Maciej Dulewicz, Jörg Hanrieder et al. · 2024 · Alzheimer s & Dementia
Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer’s disease?
Neng‐Wei Hu, Zhengtao Hu, Tomáš Ondrejčák, Pengpeng Yu, Yangyang Zhang, Yin Yang, Igor V. Klyubin, Seán Kennelly, Michael J. Rowan · 2022 · Neural Regeneration Research
Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development and therapeutic targeting
Liara Rizzi, Lea T. Grinberg · 2024 · Acta Neuropathologica Communications
Proteome dynamics from heavy water metabolic labeling and peptide tandem mass spectrometry
Ahmad Borzou, Vugar R. Sadygov, William Zhang, Rovshan G. Sadygov · 2019 · International Journal of Mass Spectrometry
Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOE ɛ 4 Carriers
Chelsea C. Hays, Zvinka Z. Zlatar, Mary J. Meloy, J Osuna, Thomas T. Liu, Douglas R Galasko, Christina E. Wierenga · 2019 · Journal of Alzheimer s Disease
In Vivo Large-Scale Mapping of Protein Turnover in Human Cerebrospinal Fluid
Sylvain Lehmann, Christophe Hirtz, Jérôme Vialaret, Maxence Ory, Guillaume Gras-Combe, Marine Le Corre, Stéphanie Badiou, Jean‐Paul Cristol, Olivier Hanon, Emmanuel Cornillot et al. · 2019 · Analytical Chemistry
Viral Delivery of Non-Mutated Human Truncated Tau to Neurons Recapitulates Key Features of Human Tauopathy in Wild-Type Mice
Thomas Vogels, Gréta Vargová, Veronika Brezováková, Wim Hendricus Quint, Tomáš Hromádka · 2020 · Journal of Alzheimer s Disease
The most valuable player or the tombstone: is tau the correct target to treat Alzheimer’s disease?
Kyan Younes, Sharon J. Sha · 2023 · Brain
Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons
Saleem, Komal, Xiao, Zichun, Zhu, Binglin, Ren, Yong, Yan, Zhen, Feng, Jian · 2026 · Molecular Psychiatry
Stratification of brain-derived extracellular vesicles of Alzheimer’s disease patients indicates a unique proteomic content and a higher seeding capacity of small extracellular vesicles
Marie Oosterlynck, Élodie Leroux, Balasubramaniam Namasivayam, Thomas Bouillet, Raphaëlle Caillierez, Anne Loyens, Danièle Mazur, Romain Perbet, Christophe Lefebvre, Soulaimane Aboulouard et al. · 2025 · Translational Neurodegeneration
Targeting tau in Alzheimer’s Disease: rationale, approach and challenges
Aram Aslanyan, Martha S. Foiani, Tatiana A. Giovannucci, Eric McDade, Karen Duff, Catherine Jane Mummery, Michael Schöll, Kristin R. Wildsmith, Ross W. Paterson · 2026 · Molecular Neurodegeneration
Association Between Plasma Apolipoprotein M With Alzheimer’s Disease: A Cross-Sectional Pilot Study From China
Jiayan Xin, Xiao Huang, Ying Hao Sun, Hai-Song Jiang, Fan Jin, Nengwei Yu, Fuqiang Guo, Fang Ye, Jun Xiao, Weidong Le et al. · 2022 · Frontiers in Aging Neuroscience
Tauomics and Kinetics in Human Neurons and Biological Fluids
Henrik Zetterberg · 2018 · Neuron
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
Anna Zettergren, Kina Höglund, Silke Kern, Valgeir Thorvaldsson, Johan Skoog, Oskar Hansson, Niels Andreasen, Nenad Bogdanović, Kaj Blennow, Ingmar Gr. Skoog et al. · 2019 · Scientific Reports
Heterogenous Genetic, Clinical, and Imaging Features in Patients with Neuronal Intranuclear Inclusion Disease Carrying NOTCH2NLC Repeat Expansion
Yusran Ady Fitrah, Yo Higuchi, Norikazu Hara, Takayoshi Tokutake, Masato Kanazawa, Kazuhiro Sanpei, Tomone Taneda, Akihiko Nakajima, Shin Koide, Shintaro Tsuboguchi et al. · 2023 · Brain Sciences
Diagnostic and therapeutic targeting of pathological tau proteins in neurodegenerative disorders
Naruhiko Sahara, Makoto Higuchi · 2023 · FEBS Open Bio
Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer’s Disease or Other Neurological Diseases
Takeshi Kawarabayashi, Takumi Nakamura, Kazuya Miyashita, Tatsuya Segawa, Isamu Fukamachi, Takashi Sugawara, Hironori Oka, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara et al. · 2023 · Journal of Alzheimer s Disease
Connecting cellular mechanisms and extracellular vesicle cargo in traumatic brain injury
Nikita Ollen‐Bittle, Austyn D. Roseborough, Wenxuan Wang, Jeng-liang D. Wu, Shawn Narain Whitehead · 2023 · Neural Regeneration Research
Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
Mohammed M. Alhadidy, Nicholas M. Kanaan · 2024 · Biochemical Society Transactions
Biofluid biomarkers for Alzheimer’s disease
Sensen Wang, Sitan Xie, Qinpin Zheng, Zhihui Zhang, Tian Wang, Guirong Zhang · 2024 · Frontiers in Aging Neuroscience
A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer's Disease
Tianle Chen, R. Matthew Hutchison, C Rubel, J. Murphy, Jin Xie, Philip H. Montenigro, Weyland Cheng, Kyle B. Fraser, Gersham W. Dent, S Hendrix et al. · 2024 · The Journal of Prevention of Alzheimer s Disease
A pathogenic Tau mutation drives autophagy-lysosome dysfunction that limits Tau degradation in a model of frontotemporal dementia
Farzaneh Sadat Mirfakhar, Jacob A. Marsh, Chihiro Sato, Kylie J. Schache, Miguel Minaya, Roland E. Dolle, Stephen C. Pak, Gary A. Silverman, David H. Perlmutter, Shannon L. Macauley et al. · 2026 · Nature Communications
Protein production is an early biomarker for RNA ‐targeted therapies
Wade K. Self, Kathleen M. Schoch, Jacob Alex, Nicolas R. Barthélemy, James G. Bollinger, Chihiro Sato, Tracy A. Cole, Holly B. Kordasiewicz, Eric E. Swayze, Randall John Bateman et al. · 2018 · Annals of Clinical and Translational Neurology
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis
Khushboo Govind Faldu, Jigna Shah · 2022 · Expert Review of Molecular Diagnostics
Astrocytes and Inflammatory Processes in Alzheimer’s Disease
Soraya Lilian Vallés, Federico Burguet, Antonio Iradi, Martı́n Aldasoro, José M. Vila, Constanza Aldasoro, Adrián Jorda · 2020 · IntechOpen eBooks
Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice
C. Facal, Iván Fernández Bessone, J. Muñiz, A. Pereyra, Olivia Pedroncini, Indiana Páez-Paz, Ramiro Clerici-Delville, Cayetana Arnaiz, Leandro Urrutia, G. Falasco et al. · 2024 · Molecular Therapy
Associations Between Free and Cued Selective Reminding Test and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment
Guido Maria Giuffrè, Davide Quaranta, Salvatore Citro, Tommaso Giuseppe Morganti, Noemi Martellacci, Maria Gabriella Vita, Paolo Maria Rossini, Paolo Calabresi, Camillo Marra · 2024 · Journal of Alzheimer s Disease
Late‐life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individuals
Therese H. Kim, Elizabeth Head, Craig E.L. Stark, Lorena Sordo, Katharine A. Kirby, Maria G. Corona, Michelle McDonnell, Joshua D. Grill, David L. Sultzer · 2025 · Alzheimer s & Dementia
Real world diagnostic performance of plasma p-tau217 for early-onset Alzheimer's disease in a cognitive disorders tertiary care setting
Pratishtha Chatterjee, Svetlana Ivanic, Adam G. Southon, Claire McCarthy, Sheila K. Patel, Maja Christensen, David Darby, Ashley Ian Bush, Scott Ayton, Emilio Werden et al. · 2025 · Journal of Alzheimer s Disease